Feasibility of behavioral activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial
Abstract Background Depression impacts the lives of millions of people worldwide. Behavioral activation (BA), derived from cognitive behavioral therapy, has the potential for improving depressive symptoms in patients with depression. Studies evaluating the effectiveness of BA specifically in the con...
Main Authors: | Alessia D’Elia, Monica Bawor, Brittany B. Dennis, Meha Bhatt, Kathryn Litke, Kathleen McCabe, Jeff Whattam, Laura Garrick, Laura O’Neill, Scott Simons, Sandra Chalmers, Brenda Key, Stefanie Goyert, Phillip Laplante, Meredith Vanstone, Feng Xie, Gordon Guyatt, Lehana Thabane, Zainab Samaan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Pilot and Feasibility Studies |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40814-020-00596-z |
Similar Items
-
Light therapy for non-seasonal depression: systematic review and meta-analysis
by: Stefan Perera, et al.
Published: (2016-03-01) -
Sociodemographic characteristics of patients with children in a methadone maintenance program: a cross-sectional study
by: Candice Luo, et al.
Published: (2019-02-01) -
Adverse outcomes associated with opioid prescription for acute low back pain: a systematic review protocol
by: Natalia Mouravska, et al.
Published: (2017-08-01) -
Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: a systematic review and meta-analysis.
by: Brittany B Dennis, et al.
Published: (2014-01-01) -
Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis
by: Meha Bhatt, et al.
Published: (2016-11-01)